Peripheral Vascular Devices | Market Insights | Japan | 2022
The continuing emergence of data supporting the safety of paclitaxel-coated devices will drive growing adoption of premium-priced DES and DCBs, supporting modest growth overall in the Japanese PV device market through 2030. Market revenues will be hindered by the impact of COVID-19 pandemic in the short term and by ASP declines caused by biennial reimbursement cuts by the MHLW over the forecast period.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PV devices in Japan across an 11-year period.